IMCC Stock Analysis and what to expect with IMCC stock ahead

AbbVie concludes acquisition of ImmunoGen for $10.1bn

Share this article ImmunoGen’s pipeline complements the existing oncology portfolio of AbbVie. Credit: JHVEPhoto / Shutterstock.com. AbbVie has completed the acquisition of ImmunoGen for $10.1bn,

February 13, 2024

Formation Bio secures $372m funds to advance drug platform

The company’s technology platforms and processes aim to expedite all aspects of drug development and trials. Credit: Pickadook / Shutterstock. Formation Bio has secured $372m

June 27, 2024

Gen Z Doesn’t Want to Answer Your Call: How Providers Can Customize Communications

John Zimmerer, VP of Vertical Marketing, Healthcare at Smart Communications Generation Z has never known a world without pervasive digital technology. From smartphones and social

October 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.